Cidara Therapeutics, Inc. Financial Ratios — CDTX Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-96.89	-47.93	-44.4	-59.92	-74.63	-55.5	-111.45	-62.57	-54.69	-40.05	-120.52
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	100	100	100	100	93.46	100
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-206.12	-586.72	-87.72	-51.76	-115.72	-13,793.65
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-199.49	-595.42	-85.24	-51.98	-116.22	-13,811.92
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-196.47	-597.59	-85.67	-51.69	-107.65	-13,356.16
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-196.47	-597.59	-85.67	-52.11	-98.49	-13,319.76
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-196.47	-620.48	-85.67	-52.11	-98.49	-13,319.76
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	14.9	- -	3.69	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	1	- -	- -	10	10	10	12	8	5	1	5	4
ST Debt	- -	- -	- -	- -	3	10	11	8	4	1	1	2
LT Debt	1	- -	- -	10	7	- -	1	- -	1	- -	4	2
Total Debt/EBITDA	-1.37	- -	- -	-0.21	-0.18	-0.16	-0.27	-0.11	-0.12	-0.04	-0.18	-0.02
Net Debt/EBITDA	-1.2	2.32	1.96	1.58	0.93	1.03	0.93	0.41	1.31	0.98	1.33	1.08
Total Debt/EBIT	-1.37	- -	- -	-0.2	-0.18	-0.16	-0.28	-0.11	-0.12	-0.04	-0.18	-0.02
Net Debt/EBIT	-1.2	2.28	1.94	1.56	0.91	1.02	0.97	0.4	1.35	0.98	1.32	1.08
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-701.49	-54.64	-41.37	-87.56	-189.01	-276.48	-376.69	-553.91	-500.71	-881.28	-658.56	-284.58
Long-Term Debt/Equity (%)	- -	- -	- -	11.11	12.06	- -	2.49	- -	6.13	- -	- -	1.18
Long-Term Debt/Capital (%)	2,031.51	- -	- -	-11.68	-5.17	- -	-0.38	- -	-0.36	- -	-0.82	-0.32
Long-Term Debt/Total Assets (%)	737.81	- -	- -	9.16	9.12	- -	1.37	- -	1.76	- -	5.34	0.9
Total Debt/Equity (%)	-106.08	- -	- -	11.11	16.53	16.79	30.99	74.31	23.46	-8.39	-59.4	2.19
Total Debt/Capital (%)	2,031.51	- -	- -	-11.68	-7.08	-4.75	-4.73	-2.44	-1.36	-0.29	-1.12	-0.59
Total Debt/Total Assets (%)	737.81	- -	- -	9.16	12.49	12.55	17	13.18	6.72	2.55	7.28	1.66
Net Debt to Equity	-92.85	199.18	-60.21	-85.7	-85.26	-109.29	-106.52	-269.61	-264.63	226.7	435.79	-116.24
Net Debt/Capital (%)	-1,158.93	63.15	57.9	44.66	25.43	22.81	13.51	7.97	13.22	7.27	7.57	23.8
EBITDA	-1	-10	-32	-48	-55	-63	-43	-71	-43	-33	-27	-176
EBITDA-CapEx	-1	-11	-33	-48	-55	-63	-43	-71	-44	-33	-27	-176
Operating Income (Loss)	-1	-10	-32	-48	-56	-63	-42	-72	-42	-34	-27	-176

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	1.59	7.09	18	11.74	6.23	3.75	1.66	0.93	1.75	0.79	0.53	3.83
Current Ratio	1.71	7.16	18.11	11.83	6.43	3.88	2.18	1.48	2.11	1.09	0.9	4.25
Quick Ratio	1.59	7.09	18	11.74	6.26	3.88	1.66	1.22	1.91	0.93	0.74	3.86
CFO/Avg Current Liab	- -	-4.63	-5.65	-5.34	-4.75	-3.55	-1.14	-1.58	-0.7	-0.76	-0.41	-3.02
Common Equity/Total Assets	-701.49	-54.64	-41.37	-87.56	-189.01	-276.48	-376.69	-553.91	-500.71	-881.28	-658.56	-284.58
Long-Term Debt/Equity (%)	- -	- -	- -	11.11	12.06	- -	2.49	- -	6.13	- -	- -	1.18
Long-Term Debt/Capital (%)	2,031.51	- -	- -	-11.68	-5.17	- -	-0.38	- -	-0.36	- -	-0.82	-0.32
Long-Term Debt/Total Assets (%)	737.81	- -	- -	9.16	9.12	- -	1.37	- -	1.76	- -	5.34	0.9
Total Debt/Equity (%)	-106.08	- -	- -	11.11	16.53	16.79	30.99	74.31	23.46	-8.39	-59.4	2.19
Total Debt/Capital (%)	2,031.51	- -	- -	-11.68	-7.08	-4.75	-4.73	-2.44	-1.36	-0.29	-1.12	-0.59
Total Debt/Total Assets (%)	737.81	- -	- -	9.16	12.49	12.55	17	13.18	6.72	2.55	7.28	1.66
CFO/Total Liabilities	-65.54	-21.54	-428.23	-211.74	-258.72	-283.91	-91.62	-109.46	-46.94	-45.98	-29.81	-342.86
CFO/CapEx	- -	-7.78	-22.19	-99.18	-163.1	-320.37	-815.2	-292.53	-615.41	-241.3	-44.42	-1,368.47
Altman's Z-Score	-27.1	-1.15	16.42	3.18	-0.28	-3.87	-4.19	-10.11	-6.86	-12.7	-9.77	-3.79

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	16.23	2.16	6	11.52	2.34	0.16
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	22.49	169.16	60.86	31.68	156.05	2,257.13
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.5	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	730.6	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.92	-1.65
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	125	-220.9
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	761.65	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-574.55	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	170	151	119	59	112	83	67	53	69	171
- Cash & Cash Equivalents	- -	23	63	85	61	75	50	36	60	33	36	190
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	- -	- -	10	10	10	12	8	5	1	5	4
Enterprise Value	1	-23	63	56	54	-6	73	55	12	21	39	-16
Total Capital	- -	-13	-45	-84	-140	-209	-248	-327	-372	-417	-437	-608
Total Debt/Capital (%)	2,031.51	- -	- -	-11.68	-7.08	-4.75	-4.73	-2.44	-1.36	-0.29	-1.12	-0.59
Total Debt / EV	1.14	- -	- -	0.18	0.18	-1.79	0.16	0.14	0.42	0.06	0.13	-0.23
EV/Sales	- -	- -	- -	- -	- -	- -	3.5	4.57	0.24	0.33	1.65	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	170	151	119	59	112	83	67	53	69	171
Diluted Enterprise Value	1	-23	108	75	68	-6	73	55	12	21	39	-16
EV per Share	8.47	- -	126.45	77.11	61.21	- -	50.3	26.55	4.57	6.11	8.81	- -
TTM Sales	- -	- -	- -	- -	- -	- -	21	12	50	64	23	1
TTM EBITDA	-1	-10	-32	-48	-55	-63	-43	-71	-43	-33	-27	-176
TTM Operating Income	-1	-10	-32	-48	-56	-63	-42	-72	-42	-34	-27	-176
TTM Cash Flow to Firm	-1	-8	-26	-40	-50	-57	-29	-54	-25	-28	-22	-177
TTM Free Cash Flow to Firm	-1	-7	-25	-39	-50	-57	-28	-54	-25	-28	-22	-176

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Free Cash Flow	- -	- -	-6.87	-3.83	-2.4	-1.05	-3.92	-1.53	-2.64	-1.86	-3.17	-0.97
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	1	-23	63	56	54	-6	73	55	12	21	39	-16
Low Price	- -	- -	224.51	173	112	38.8	24.45	26	22	8	11.86	10
EV/Sales	- -	- -	- -	- -	- -	- -	3.5	4.57	0.24	0.33	1.65	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-4.58	-3.43	-2.38	-1.76	-1.55	-1.7	-2.48	-1.43	-4.16	-0.53
Price/Earnings High	- -	- -	-5.89	-5.2	-3.69	-3.1	-2.82	-2.47	-3.89	-2.93	-8.01	-1.03
Price/Earnings Low	- -	- -	-3.46	-2.6	-1.76	-0.7	-0.87	-0.72	-1.36	-0.83	-2.26	-0.37
Price/Book Value	- -	- -	-3.74	-1.61	-0.8	-0.27	-0.43	-0.25	-0.18	-0.13	-0.16	-0.28
Price/Book Value Average	- -	- -	-3.24	-1.76	-0.89	-0.56	-0.25	-0.38	-0.28	-0.11	-0.22	-0.15
Price/Book Value High	- -	- -	-4.17	-2.68	-1.38	-0.98	-0.45	-0.55	-0.44	-0.24	-0.42	-0.29
Price/Book Value Low	- -	- -	-2.45	-1.34	-0.66	-0.22	-0.14	-0.16	-0.15	-0.07	-0.12	-0.1
Price/Tangible Book Value	- -	- -	1.64	1.71	1.99	1	2.95	7.76	3.09	-3.66	-8.46	1.05
Price/Tangible Book Value Average	- -	- -	1.42	1.87	2.22	2.07	1.68	11.88	4.87	-3.33	-11.62	0.55
Price/Tangible Book Value High	- -	- -	1.83	2.84	3.44	3.64	3.06	17.26	7.66	-6.82	-22.36	1.07
Price/Tangible Book Value Low	- -	- -	1.07	1.42	1.64	0.82	0.94	5.04	2.67	-1.94	-6.31	0.39
Price/Sales	- -	- -	- -	- -	- -	- -	5.34	6.89	1.34	0.82	2.98	133.87
Price/Sales Average	- -	- -	- -	- -	- -	- -	3.05	10.55	2.12	0.75	4.1	70.08
Price/Sales High	- -	- -	- -	- -	- -	- -	5.54	15.33	3.33	1.53	7.89	136.65
Price/Sales Low	- -	- -	- -	- -	- -	- -	1.7	4.48	1.16	0.43	2.23	49.8
Price/Cash Flow	- -	- -	-6.56	-3.79	-2.38	-1.04	-3.92	-1.53	-2.64	-1.86	-3.09	-0.97
Price/Cash Flow Average	- -	- -	-5.68	-4.15	-2.66	-2.16	-2.23	-2.34	-4.17	-1.69	-4.25	-0.51
Price/Cash Flow High	- -	- -	-7.31	-6.3	-4.12	-3.79	-4.06	-3.4	-6.55	-3.46	-8.18	-0.99
Price/Cash Flow Low	- -	- -	-4.29	-3.15	-1.96	-0.86	-1.25	-0.99	-2.29	-0.98	-2.31	-0.36
Price/Free Cash Flow Average	- -	- -	-5.95	-4.19	-2.68	-2.16	-2.24	-2.35	-4.17	-1.69	-4.35	-0.51
Price/Free Cash Flow High	- -	- -	-7.66	-6.36	-4.15	-3.8	-4.06	-3.41	-6.56	-3.47	-8.37	-0.99
Price/Free Cash Flow Low	- -	- -	-4.49	-3.18	-1.98	-0.86	-1.25	-1	-2.29	-0.99	-2.36	-0.36
EV/Sales Average	- -	- -	- -	- -	- -	- -	1.2	8.23	1.02	0.26	2.77	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	3.69	13.01	2.23	1.04	6.56	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	2.16	0.06	- -	0.9	- -
EV/EBITDA Average	-1.2	2.32	-2.67	-1.88	-1.49	-0.92	-0.58	-1.4	-1.16	-0.5	-2.39	0.55
EV/EBITDA High	-1.2	2.32	-3.99	-3.67	-2.81	-2.4	-1.79	-2.22	-2.54	-2.01	-5.67	0.07
EV/EBITDA Low	-1.2	2.32	-1.53	-1.04	-0.85	0.25	0.07	-0.37	-0.07	0.11	-0.78	0.7
EV/EBIT Average	-1.2	2.28	-2.63	-1.85	-1.47	-0.91	-0.6	-1.38	-1.2	-0.49	-2.38	0.55
EV/EBIT High	-1.2	2.28	-3.94	-3.61	-2.78	-2.38	-1.85	-2.18	-2.62	-2	-5.64	0.07
EV/EBIT Low	-1.2	2.28	-1.51	-1.03	-0.84	0.25	0.07	-0.36	-0.07	0.11	-0.77	0.7
Last Price	- -	- -	343.2	208	136	47	76.8	40	25.4	15.13	15.88	26.88
High Price	- -	- -	382.6	345.9	235	171	79.6	89	63	28.2	42	27.44
Enterprise Value Average	1	-23	85	90	82	58	25	99	51	17	64	-97
Enterprise Value High	1	-23	127	175	155	150	77	157	111	67	153	-12
Enterprise Value Low	1	-23	49	50	47	-16	-3	26	3	-4	21	-123

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	1	1	1	1	1	1	2	2	3	4	5	11
Diluted Weighted Avg Shares	- -	1	- -	1	1	1	1	2	3	3	4	6
Basic Weighted Avg Shares	- -	1	- -	1	1	1	1	2	3	3	4	6
Revenue per Share	- -	- -	- -	- -	- -	- -	14.38	5.81	18.9	18.45	5.33	0.2
EBITDA per Share	-7.06	-15.5	-64.22	-65.85	-62.92	-49.92	-29.64	-34.07	-16.58	-9.55	-6.16	-27.7
Operating Income per Share	-7.06	-15.78	-65.14	-66.86	-63.68	-50.34	-28.68	-34.58	-16.11	-9.59	-6.19	-27.73
Basic EPS, GAAP	-8.77	-18.74	-64.9	-66.49	-63.69	-55.16	-28.25	-36.03	-16.19	-9.61	-5.25	-26.75
Basic EPS from Cont Ops	-8.77	-18.74	-64.9	-66.49	-63.69	-46.94	-28.25	-34.7	-16.19	-9.61	-5.74	-26.82
Diluted EPS, GAAP	-8.77	-18.74	-64.9	-66.49	-63.69	-55.16	-28.25	-36.03	-16.19	-9.61	-5.25	-26.75
Diluted EPS from Cont Ops	-8.77	-18.74	-64.9	-66.49	-63.69	-46.94	-28.25	-34.7	-16.19	-9.61	-5.74	-26.82
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-6.84	-12.15	-52.33	-54.9	-57.04	-45.11	-19.61	-26.19	-9.62	-8.15	-5.13	-27.8
Free Cash Flow per Basic Share	-6.84	-13.71	-54.69	-55.45	-57.39	-45.25	-19.64	-26.28	-9.64	-8.19	-5.25	-27.82
Cash & Equivalents per Share	1.21	35.92	216.75	144.41	86.07	59.31	34.56	17.28	22.76	9.37	8.18	29.9
Book Value per Share	-9.2	-20.96	-91.72	-129.28	-170.72	-173.99	-178.62	-161.08	-143.81	-119.81	-100.98	-96.27
Tangible Book Value per Share	-9.12	-18.03	209.49	121.72	68.28	47.04	26.01	5.16	8.23	-4.13	-1.88	25.72

Cidara Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)